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Primary Prevention of Sudden Cardiac death in post-infarction patients especially those with
ejection fraction less than 35% is best achieved by implantable defibrillator. However, the cost
of Quality Adjusted Life Years saved is $ 50,000e70,000, makes implantable defibrillators not
an easily acceptable optionwhen preventing SCD in a significant number of patientswith low
ejection fraction of 35 percent. In, addition excessive dependence on ejection fraction, ex-
cludes a large number of postinfarction patients with ejection fraction more than 35 percent,
or patients with existing but not known heart disease. The two complementary strategies
based on Public Health approach and Home AED approach and strengthening the program of
Bystander CPR and AED application of publically available AED may be a better way for Pri-
mary Prevention of SCD in more number of patients. These approaches may be considered
seriously to reduce sudden cardiac death in India, however, it needs to be proven.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Definition
Death from cardiac arrest occurring within one hour of onset
of symptoms is referred to as Sudden Cardiac Death or SCD. It
is characterized by unexpected cardiovascular collapse from
an underlying cardiac cause. Primary Prevention is preventing
SCD in people who are at risk for sudden cardiac death, but
have never had cardiac arrest which can lead to sudden car-
diac death.2. Epidemiology
Sudden Cardiac Death (SCD) from cardiac arrest is the most
common cause of death worldwide, accounting for more than, Suite 158, Phoenix, AZ,
ociety of India. All rights50 percent of all cardiovascular deaths worldwide. There are
approximately 166,200e250,000 out-of hospital SCD annually
in the United States.1 This accounts for about 38e50% of all
cardiac deaths. Themedian survival fromSCD is only 6.4%.1 In
the majority of patients who suffer SCD, the underlying
mechanism is Ventricular fibrillation. While effective cardio-
pulmonary resuscitation (CPR) can improve survival, the
most effective treatment of ventricular fibrillation is very early
defibrillation.2,33. Who is at high risk for SCD
Primary Prevention of SCD is best possible if we can identify
those people who are at risk for SCD.85032, USA.
reserved.
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those with reduced left ventricular ejection fraction. Many
primary preventions trials including MADIT-1, MADIT-2,
MUSTT, and SCD-HeFT4e7 have shown that patients with
previous myocardial infarction with left ventricular ejection
fraction of less than 35% had 2 year all-cause mortality of
22e32%. The SCD-HeFT trial also included patients with non-
ischemic cardiomyopathy and found similar mortality risk.4. Interestingly, a large majority of SCDs
happen in people with no “known” pre-existing
heart disease
In fact, most SCDs in absolute terms occur in patients with no
known pre-existing known heart disease. As seen in Fig. 1, it is
evident that the incidence of SCD is about 20% per year in
patients with heart failure and those with arrhythmia
markers, compared with about 1e2% in general population,
who are patients with no “known” pre-existing heart disease.
On the other hand the absolute numbers of SCD are signifi-
cantly much higher about 325,000 per in year in the general
population compared with just about 20,000 in patients with
heart failure and arrhythmia markers.85. What do the guidelines state about
primary prevention of sudden cardiac death?
Implantable Cardioverter Defibrillators (ICD) is recommended
for primary prevention of SCD, in patients with ischemic or
non-ischemic cardio-myopathy, with left ventricular ejection
fraction of less than 35% with the following exclusions.9,10
1. Within 3 months of myocardial re-vascularization
2. Within 40 days of myocardial infarction
3. Within 90 days of initial diagnosis of non-ischemic
cardiomyopathy
4. Cardio-genic shock6. What are the problems with current
guidelines?
1. Excludes a large number of patients at risk, who have not
yet been identified to have heart disease, as shown in Fig. 1Fig. 1 e Estimates of Incidence and Events of SCD in Ge2. High Cost of therapy. The estimated cost range of quality
adjusted year of life saved is $34,000-$ 70, 200 in the MADIT
and SCD-HeFT trial.11 This excludes a lot of people
3. Excessive dependence of left ventricular ejection fraction
in post-infarction patients. Excludes post-infraction pa-
tients with ejection fraction more than 35 percent.7. What is the alternative to the guidelines?
The two complementary alternate strategies mentioned
below, which need to be strengthened/reinforced to make
primary prevention of sudden cardiac death possible in more
people, include.
1. Public Health Approach: Primary Prevention of SCD by
Bystander CPR (cardio-pulmonary resuscitation) and Pub-
lically Accessible AED in General population. It has been
shown that there is a 74% chance of survival from SCD, if
the AED is applied within 3 min of onset of collapse.2 The
Public Access Defibrillation trial12 studied the benefit of
early defibrillation, and has shown that with effective
Bystander CPR and early application of available Auto-
mated External Defibrillator by Bystanders, the survival
from SCD in general population can be significantly
improved. The trial included 19000 volunteer responders in
993 community units, which included shopping malls,
apartment complexes and hotels. Nearly 30% volunteers
were just high school students. In case of cardiac arrest the
volunteers were notified thru pager or telephone. The
study showed nearly 30% survival with CPR and early
defibrillation by a publically accessible defibrillator
compared with only 15% with CPR alone. All patients
received continuation of resuscitative efforts by trained
paramedic personnel of the emergency medical services
after their arrival.
We in India, should also pay strong emphasis on building
Bystander CPR programs, and train lay people in use of AED.
This is probably the most cost effective way to improve sur-
vival from first episode of cardiac arrest or those with no
known pre-existing heart disease (which may be plenty in
India).
2. Home AED Approach: Primary Prevention of SCD by Family
member performed CPR and Home AED in patients at highneral population and patients with heart disease.
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by publicly available AED, the effect of such programs is
limited, since, studies have shown that 80% of all out-of
hospital SCDs occur at home.13,14 Unfortunately, the suc-
cessful resuscitation of SCD at home is extremely poor at
only 2%.14 The Home AED Trial (HAT) reported in 2008,15
which included 7001 patients, randomized to the Study
group, those recommended initial treatment of SCD at
home by Family member performed CPR and AED Appli-
cation or the Control group with recommended initial
resuscitation solely attempted by trained paramedics of
the Emergency Medical Services called in case of SCD. Pa-
tients who initially received resuscitative attempts
including AED use by family members, received continued
resuscitative efforts by paramedics of the emergency
medical services on arrival. It was found that the Family
member performed CPR and AED use was successful in
preventing sudden cardiac death in about 12% patients
who suddenly collapsed at home. This was higher than the
2% survival in other studies,15 of survival from SCD at
home. The study however, did not find show significant
reduction in total mortality rate with the strategy of initial
Familymember performedCPR andAEDuse (mortality rate
6.4%), compared with CPR and AED use by conventional
community based emergency medical services or the
Control group (mortality rate 6.5%), which were called in
case of sudden collapse. According to the authors, the lack
of benefit in the study was due to factors which included, a
low or less than 1 percent incidence of SCD, probably
because the study only included post-infarction patients,
who had ejection fraction more than 35% and thus were
not candidates for ICD therapy. It remains to be seen if
Home AED and familymember performed CPR can prevent
SCD in post-infarction patients or those with ejection
fraction less than 35%, who cannot afford ICD therapy
compared with community based emergency cardiac care
services, in less industrialized or developing countries.
This is especially important since, in many developing
countries, the community based emergency cardiac care
services are not as well developed or are overwhelmed or
delayed due to traffic issues.8. Conclusions
Primary Prevention of Sudden Cardiac death in post-
infarction patients especially those with ejection fraction
less than 35% is best achieved by implantable defibrillator.
However, the cost of Quality Adjusted Life Years saved is $
50,000e70,000, makes implantable defibrillators not an easily
acceptable option when preventing SCD in a significant
number of patientswith low ejection fraction of 35 percent. In,
addition excessive dependence on ejection fraction, excludes
a large number of post-infarction patients with ejection frac-
tion more than 35 percent, or patients with existing but not
known heart disease. The two complementary strategies
based on Public Health approach andHomeAEDapproach and
strengthening the program of Bystander CPR and AED appli-
cation of publically available AED may be a better way forPrimary Prevention of SCD in more number of patients. This
requires training more lay people, students, family and
friends in CPR and AED use. This training can be easily
imparted even to middle school and high school children and
adults. American Heart Association and other organizations
have designed simple and effective training courses in CPR
and AED use for lay people. Home AED application and Family
member performed CPR in post-infarction patients with
mildly reduced ejection fraction (more than 35%) is an alter-
native, however, its superiority to community based emer-
gency medical services has not been proven in the
industrialized developed countries. It remains to be seen if
Home AED use can be feasible in developing countries with
less well organized or overwhelmed emergency medical ser-
vices. Our Challenge to the current guidelines for primary
prevention of sudden cardiac death, is to device strategies
which are more cost-effective, which benefit more patients
both with “known” and “not known” but pre-existing heart
disease, taking into consideration our huge patient popula-
tion, lack of good community based emergency medical ser-
vices. We do however, have high population density homes
where a Home AED or Public AED may be life-saving, but it
needs to be proven.Conflicts of interest
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